XML 22 R33.htm IDEA: XBRL DOCUMENT v3.19.3
EQUITY AND NONCONTROLLING INTERESTS (Tables)
 9 Months Ended
Sep. 28, 2019
Equity [Abstract]  
Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
 
Three Months Ended
 
Nine Months Ended
 
September 28, 2019
 
September 29, 2018
 
September 28, 2019
 
September 29, 2018
 
(in thousands)
Numerator:
 
 
 
 
 
 
 
Income from continuing operations, net of income taxes
$
73,552

 
$
60,902

 
$
173,549

 
$
167,020

Income from discontinued operations, net of income taxes
—

 
—

 
—

 
1,506

Less: Net income attributable to noncontrolling interests
742

 
534

 
1,878

 
1,818

Net income attributable to common shareholders
$
72,810

 
$
60,368

 
$
171,671

 
$
166,708

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average shares outstanding - Basic
48,818

 
48,310

 
48,682

 
48,098

Effect of dilutive securities:
 
 
 
 
 
 
 
Stock options, restricted stock units, performance share units and restricted stock
897

 
1,016

 
945

 
1,020

Weighted-average shares outstanding - Diluted
49,715

 
49,326

 
49,627

 
49,118
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
 
Foreign Currency Translation Adjustment
and Other
 
Pension and Other Post-Retirement Benefit Plans
 
Total
 
(in thousands)
December 29, 2018
$
(102,199
)
 
$
(70,504
)
 
$
(172,703
)
Other comprehensive loss before reclassifications
(8,261
)
 
—

 
(8,261
)
Amounts reclassified from accumulated other comprehensive loss
—

 
1,113

 
1,113

Net current period other comprehensive income (loss)
(8,261
)
 
1,113

 
(7,148
)
Income tax expense (benefit)
(1,615
)
 
234

 
(1,381
)
September 28, 2019
$
(108,845
)
 
$
(69,625
)
 
$
(178,470
)
Rollforward Redeemable Noncontrolling Interest
The following table provides a rollforward of the activity related to the Company’s redeemable noncontrolling interests:
 
Nine Months Ended
 
September 28, 2019
 
September 29, 2018
 
(in thousands)
Beginning balance
$
18,525

 
$
16,609

Adjustment to Vital River redemption value
1,451

 
1,111

Purchase of Vital River 5% equity interest
(8,745
)
 
—

Change in fair value of Vital River 8% equity interest, included in additional-paid-in-capital
2,708

 
—

Modification of Vital River 8% purchase option
2,196

 
—

Acquisition of a 10% non-controlling interest through acquiring Citoxlab
4,035

 
—

Acquisition of a 20% non-controlling interest through acquiring a supplier
8,740

 
—

Net income attributable to noncontrolling interests
249

 
543

Foreign currency translation
(814
)
 
(932
)
Ending balance
$
28,345

 
$
17,331